Our research involves the application of nutrition and nutrigenetics to the nutraceutical prevention and post-onset management of type 2 diabetes in humans, with a view to the reduction of polypharmacy.
Supports high-throughput genomics projects including those requiring DNA sequencing, next generation sequencing, single cell analysis, and cell sorting.